Skip to main content
    I

    Immuneering Corp (IMRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.52
    -0.19 (-5.12%)

    Market Cap: $240.27M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Immuneering Corp (IMRX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Immuneering are Kyverna Therapeutics, Inc. Common Stock (KYTX), CorMedix (CRMD) and NeOnc Technologies Holdings, Inc. Common Stock (NTHI). By market cap, Immuneering ranks 9th of the 13 companies on this page; Immix Biopharma (IMMX) is the largest at $657.09M.

    Peer Comparison

    IMRX's revenue growth of -99.8% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Immuneering (IMRX)$240.27MN/AN/A0.0%N/A-99.8%0.00%
    Kyverna Therapeutics, Inc. Common Stock (KYTX)$319.27MN/AN/A0.0%-81.5%0.0%0.00%
    CorMedix Inc (CRMD)$370.64M6.3x0.9x15.5%13.9%-47.7%0.00%
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)$141.66MN/AN/A0.0%N/A-100.0%0.00%
    Inovio Pharmaceuticals Inc (INO)$267.85MN/A462.0x0.0%N/A-100.0%0.00%
    Indaptus Therapeutics Inc (INDP)$422.38MN/AN/A0.0%N/A0.0%0.00%
    Immunic Inc (IMUX)$102.61MN/AN/A0.0%N/A0.0%0.00%
    Rocket Pharmaceuticals Inc (RCKT)$256.82MN/AN/A0.0%-2.3%0.0%0.00%
    Bright Minds Biosciences Inc (DRUG)$227.96MN/AN/A0.0%-11.2%0.0%0.00%
    Century Therapeutics Inc (IPSC)$299.63MN/AN/A0.0%N/A-100.0%0.00%
    Keros Therapeutics Inc (KROS)$202.13MN/A4.9x-151.4%N/A180.5%0.00%
    Immix Biopharma Inc (IMMX)$657.09MN/AN/A0.0%-14.9%0.0%0.00%
    Prelude Therapeutics Inc (PRLD)$275.32MN/A16.3x-269.7%N/A41.0%0.00%
    Peer median$271.59M6.3x10.6x0.0%-11.2%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Immuneering, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Kyverna Therapeutics, Inc. Common Stock (KYTX)
    Kyverna Therapeutics, Inc. is an innovative biotechnology company focused on advancing immunotherapies for autoimmune diseases and other significant health...
    KYTX competitors
    CorMedix Inc (CRMD)
    CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious...
    CRMD competitors
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
    NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy...
    NTHI competitors
    Inovio Pharmaceuticals Inc (INO)
    Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development...
    INO competitors
    Indaptus Therapeutics Inc (INDP)
    Indaptus Therapeutics Inc. is a pioneering biotechnology firm focused on advancing immunotherapies that aim to transform cancer treatment paradigms.
    INDP competitors
    Immunic Inc (IMUX)
    Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune...
    IMUX competitors
    Rocket Pharmaceuticals Inc (RCKT)
    Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases.
    RCKT competitors
    Bright Minds Biosciences Inc (DRUG)
    Bright Minds Biosciences Inc. (DRUG) is a forward-thinking clinical-stage biotechnology firm specializing in the development of groundbreaking therapies...
    DRUG competitors
    Century Therapeutics Inc (IPSC)
    Century Therapeutics Inc. (Ticker: IPSC) is a leading biotechnology company specializing in allogenic cell therapy...
    IPSC competitors
    Keros Therapeutics Inc (KROS)
    Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery...
    KROS competitors
    Immix Biopharma Inc (IMMX)
    Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology...
    IMMX competitors
    Prelude Therapeutics Inc (PRLD)
    Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized...
    PRLD competitors

    Frequently Asked Questions About IMRX

    Who are Immuneering's main competitors?

    The companies most similar to Immuneering include Kyverna Therapeutics, Inc. Common Stock (KYTX), CorMedix (CRMD), NeOnc Technologies Holdings, Inc. Common Stock (NTHI), Inovio Pharmaceuticals (INO) and Indaptus Therapeutics (INDP), listed from the closest match.

    Who is Immuneering's biggest competitor?

    Immix Biopharma (IMMX) is the largest of the similar companies at $657.09M; Kyverna Therapeutics, Inc. Common Stock (KYTX) is the closest match by business profile, size, sector and industry.

    How does IMRX stock compare with its competitors?

    IMRX's net margin is 0.0% against a peer median of 0.0%.

    Which of Immuneering's competitors pays a higher dividend?

    Immuneering pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Immuneering bigger than its competitors?

    No. Immuneering is 9th by market cap among the 13 companies on this page; the largest is Immix Biopharma (IMMX) at $657.09M.